Repeated cannabinoid administration increases indices of noradrenergic activity in rats
about
Cannabis Use during Adolescent Development: Susceptibility to Psychiatric IllnessHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression ComorbidityCannabinoid and opioid interactions: implications for opiate dependence and withdrawalCannabinoid modulation of noradrenergic circuits: implications for psychiatric disordersGlucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory.The endocannabinoid system in anxiety, fear memory and habituation.Endocannabinoid signaling in the etiology and treatment of major depressive illness.Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortexSynthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult ratsCannabinoid modulation of cortical adrenergic receptors and transporters.Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons.Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways.Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.Cannabinoids and novelty investigation: influence of age and duration of exposureStress system changes associated with marijuana dependence may increase craving for alcohol and cocaine.The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortexStress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.Contrasting Regulation of Catecholamine Neurotransmission in the Behaving Brain: Pharmacological Insights from an Electrochemical Perspective.Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion.Contribution of limbic norepinephrine to cannabinoid-induced aversion.Cannabinoid modulation of limbic forebrain noradrenergic circuitry.Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress.
P2860
Q21090462-E2AD6122-9839-4EDA-9F47-91BEEA83BFA3Q26784030-73E3BC13-F5EE-446B-B378-D055982BE9CCQ27000762-F6314B94-1E8C-42A5-BC8B-7F000037498BQ27001139-99FFE6BB-25C1-46E4-A67A-CDF4F74EAF02Q30464452-2616D92A-6D59-41E0-B1B8-285D3BCEB0D1Q30471032-D870C0E9-E29E-4045-ADBF-276837771121Q30687668-EC6147BD-2EBE-4CF0-9DBD-0DB5494CCE47Q33715462-816CBC6A-B6C0-46D0-82CD-81A995ECCA66Q34381331-D4253BEC-EA05-428F-89C5-9DB941F7EF6DQ34617484-8F6BF090-895A-4B6C-8CCB-0B269D6A093AQ35547422-0A256E76-7AF3-4ACE-8D7B-BF940979A1A4Q35754854-23BD53A0-2047-48FD-A079-E025F31E8C3EQ35972392-BBFEBBF9-3C3A-47C4-AF69-00DD83ECCEC2Q36174329-93018278-317C-419B-86BF-9AB48F759936Q36417706-2C91FB40-3E2F-4DE3-B19A-A8FEE38A7A7BQ36450080-EFF9814C-5FA3-470E-A1B2-5606159A6A27Q36863128-C6A06234-8A61-4D91-9DAF-8E53BCCD5E49Q36943239-B57C6C1B-E3D5-41D4-94B4-947A566E1697Q37142233-7CEBFF8A-1FFE-45C3-98A6-A21A7F9EBB33Q37240007-7448CC78-2608-4EC3-804B-B2BF288179D0Q37529127-F77B7C2B-0BBC-4BC2-8A58-3BCC63AA02C4Q38877585-8E8CBA85-647C-41E5-9458-6824642B78AAQ39166257-99CF41FB-3B7C-47C0-A24B-C3F2FBF24112Q39658389-A3E86FBF-594E-4FDC-9E87-575473A0CE0EQ40851777-6C30A0AA-E6E7-4E0F-98A3-1486224B0DA7Q40862739-E00C75F5-4498-47BE-BA8F-E1599FC83C2DQ43097962-A62EA886-4143-4E91-83FB-309A6A9C04D0Q48283351-8F63BFAA-61AF-4827-A8C9-45ACF997081DQ48379311-3DCCE6A1-DD24-41E2-8F44-07474FAA124D
P2860
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@ast
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@en
type
label
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@ast
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@en
prefLabel
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@ast
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@en
P2093
P2860
P1476
Repeated cannabinoid administration increases indices of noradrenergic activity in rats
@en
P2093
E J Van Bockstaele
S E Sparks
V C Oropeza
P2860
P304
P356
10.1016/J.PBB.2006.12.020
P407
P50
P577
2007-01-09T00:00:00Z